Barely Significant
← all excerpts

Is Cystoscopic Intravesical Injection of OnabotulinumtoxinA Acceptable in an Outpatient Clinic?

Int Neurourol J · 2025 · PMC12010894 · PMID 40211836

Europe PMCDOI
1
hedged sentence
0.1000
closest p · 2.0× alpha
0.1000
boldest claim

The sentences

did not reach statistical significanceP=0.100so close (0.05 < p ≤ 0.1)
Forty-one percent of participants who underwent diagnostic cystoscopy reported experiencing symptoms postprocedure, compared to 24% who had intravesical onabotulinumtoxinA injection (OR, 2.22; 95% CI, 0.94–5.20), though this again did not reach statistical significance (P=0.100).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.